BUZZ-Indian pharma stocks up on report US taps drugmakers for critical cancer drug

** Shares of Indian pharma companies .NIPAHRM gain 1.8%

** US FDA has reached out to Indian drugmakers for a critical cancer drug ifosfamide which is in short supply due to manufacturing disruptions in US, Mint reports citing sources

** Drug regulator sends SOS to Indian Drug Manufacturers' Association to identify potential manufacturers capable of supplying ifosfamide, report adds

** All but one of 20 stocks on sub-index in green with gains led by Piramal Pharma's PIRM.NS 9.8% jump

** Cipla CIPL.NS and Alkem Laboratories ALKE.NS rise ~2% each

** US FDA and IDMA did not immediately respond to Reuters requests for comment

** YTD, pharma index up 10.8% vs Nifty 50's .NSEI 7.7% decline



This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.